Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma
Guohe Song(Shanghai First People's Hospital), Qiang Gao(Fudan University), Jiaqiang Ma(National University of Defense Technology), Yang Shi(Peking University), Ai‐Wu Ke(Fudan University), Yingcheng Wu(Stanford University), Shuyi Ji(Shanghai East Hospital), Jian Lin(Fudan University), Yifei Cheng(Fudan University), Ruibin Xi(Peking University), Youpei Lin(Ministry of Education), Jiaxin Li(Peking University), Xiaoying Wang(Fudan University), Xiaoliang Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Juan Zhang(Zhongnan Hospital of Wuhan University), Shu Zhang(Nantong University), Xiaoming Zhang(Institute of Infection and Immunity), Yuming Liu(Nankai University), Shan Jiang(Duke Medical Center), Ya Cao(Ministry of Education of the People's Republic of China), Jia Fan(Fudan University), Jian Zhou(Fudan University Shanghai Cancer Center), Shuaixi Yang(Fudan University), Siyuan Huang(Peking University), Meng Lu(Air Force Medical University), Yuan Ji(Sun Yat-sen University), Dongning Rao(Fudan University)
Cited by 154
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|977
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors
|Nature|2011|860
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828